About Us

We are a biotechnology company focused on the development and commercialization of novel personalized therapeutics to treat cancer. 

We are developing Vigil, our proprietary immunotherapy platform in multiple advanced cancer indications.

• Leadership Team
• Board of Directors
• Scientific Advisory Board